These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18787405)

  • 21. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
    Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
    Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development.
    Mochida GH; Ganesh VS; de Michelena MI; Dias H; Atabay KD; Kathrein KL; Huang HT; Hill RS; Felie JM; Rakiec D; Gleason D; Hill AD; Malik AN; Barry BJ; Partlow JN; Tan WH; Glader LJ; Barkovich AJ; Dobyns WB; Zon LI; Walsh CA
    Nat Genet; 2012 Nov; 44(11):1260-4. PubMed ID: 23023333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
    Takahashi N; Fukushima T; Yorita K; Tanaka H; Chijiiwa K; Kataoka H
    Int J Cancer; 2010 Apr; 126(7):1611-20. PubMed ID: 19711349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma.
    Batchu RB; Qazi AM; Gruzdyn OV; Semaan A; Seward SM; Chamala S; Dhulipala VB; Bouwman DL; Weaver DW; Gruber SA
    Surgery; 2013 Oct; 154(4):739-46; discussion 746-7. PubMed ID: 24074410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects.
    Borchardt H; Schulz A; Datta K; Muders MH; Aigner A
    Sci Rep; 2019 Oct; 9(1):15471. PubMed ID: 31664117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
    Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
    Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
    Xia W; Bai H; Deng Y; Yang Y
    J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis.
    Yamanaka S; Sunamura M; Furukawa T; Sun L; Lefter LP; Abe T; Yatsuoka T; Fujimura H; Shibuya E; Kotobuki N; Oshimura M; Sakurada A; Sato M; Kondo T; Matsuno S; Horii A
    Lab Invest; 2004 Oct; 84(10):1339-51. PubMed ID: 15300227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis.
    Li F; Yuan P; Rao M; Jin CH; Tang W; Rong YF; Hu YP; Zhang F; Wei T; Yin Q; Liang T; Wu L; Li J; Li D; Liu Y; Lou W; Zhao S; Liu MF
    Nat Cell Biol; 2020 Apr; 22(4):425-438. PubMed ID: 32203416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.